A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
June 14, 2022 updated by: University of Colorado, Denver
DECIDE - ICD: A Multicenter Trial of a Shared DECision Support Intervention for Patients Offered Implantable Cardioverter-DEfibrillators
The investigators goal is to assess real-world effectiveness of patient decision aids (PtDA) for high-risk decisions using the implantable cardioverter-defibrillator (ICD) as a model.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators propose the DECIDE-ICD trial: a type II effectiveness implementation hybrid trial of the investigators ICD PtDAs. The Investigators will use a 6-site stepped-wedge design, with implementation guided by normalization process theory® and evaluation guided by the RE-AIM framework.
The investigators aim to evaluate reach and effectiveness of the ICD PtDAs using a pragmatic, stepped-wedge design on decision quality (knowledge and value-concordance) and psychosocial outcomes.
- Hypothesis 1a: PtDAs will reach over 50% of eligible patients.
- Hypothesis 1b: ICD PtDAs will be effective in improving decision quality in real-world practice.
- Hypothesis 1c: Better informed patients will have lower anxiety, higher rates of planning for the possibility of deactivation, and increased identification of a surrogate decision maker.
The investigators propose 3 a priori hypotheses:
- The decision aids will have a differential effect on the decisions of participants by age (>= 70 years old vs <70 years old);
- The decision aids will have a differential effect on the decisions of participants by heart failure type (non-ischemic vs ischemic);
- The decision aids will have a differential effect on the decisions of participants by the type of device they are considering (ICD vs ICD replacement vs CRT-D).
Along with these hypotheses, we recognize that other important covariates exist, such as health literacy and education level.
Study Type
Interventional
Enrollment (Actual)
790
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Denver
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years or older
- English-speaking (videos and surveys have only been validated in English)
- Patients have been offered a primary prevention ICD for initial implant, reimplantation, or CRT with defibrillation
Exclusion Criteria:
- Prisoners
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Participants will fill out surveys
These participants will fill out surveys in regard to their experiences, opinions, and knowledge of the defibrillator process.
|
|
|
Active Comparator: Educational video and/or handout
These participants will receive an educational video and/or handout about the defibrillator process.
Then they will fill out surveys in regard to their experiences, opinions, and knowledge of the defibrillator process.
|
The intervention includes a video and/or handout (whichever is easier for the participant) that will give information about defibrillators and about other patients' experiences with their decisions about defibrillators.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge About Defibrillation at Baseline
Time Frame: Baseline
|
Multiple survey responses by participants will indicate knowledge changes over time.
The Decision Quality Knowledge Survey measures knowledge about defibrillators.
Possible scores range from 0 to 100, with higher scores indicating more knowledge and better outcomes.
|
Baseline
|
|
Knowledge About Defibrillation at 1 Month
Time Frame: 1 month
|
Multiple survey responses by participants will indicate knowledge changes over time.
The Decision Quality Knowledge Survey measures knowledge about defibrillators.
Possible scores range from 0 to 100, with higher scores indicating more knowledge and better outcomes.
|
1 month
|
|
Knowledge About Defibrillation at 6 Months
Time Frame: 6 months
|
Multiple survey responses by participants will indicate knowledge changes over time.
The Decision Quality Knowledge Survey measures knowledge about defibrillators.
Possible scores range from 0 to 100, with higher scores indicating more knowledge and better outcomes.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reach of Eligible Patients
Time Frame: Baseline
|
Measuring how many patients of the eligible patient base are able to view or read the educational materials.
|
Baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differential Effect by Age
Time Frame: Baseline, 1 month, 6 months
|
The decision aids will have a differential effect on the decisions of participants by age (>= 70 years old vs <70 years old)
|
Baseline, 1 month, 6 months
|
|
Differential Effect by Heart Failure Type
Time Frame: Baseline, 1 month, 6 months
|
The decision aids will have a differential effect on the decisions of participants by heart failure type (non-ischemic vs ischemic)
|
Baseline, 1 month, 6 months
|
|
Differential Effect by Type of Device
Time Frame: Baseline, 1 month, 6 months
|
The decision aids will have a differential effect on the decisions of participants by the type of device they are considering (ICD vs ICD replacement vs CRT-D).
|
Baseline, 1 month, 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Daniel D Matlock, MD, MPH, University of Colorado, Denver
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 28, 2018
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2021
Study Registration Dates
First Submitted
November 29, 2017
First Submitted That Met QC Criteria
December 11, 2017
First Posted (Actual)
December 15, 2017
Study Record Updates
Last Update Posted (Actual)
July 8, 2022
Last Update Submitted That Met QC Criteria
June 14, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-1697
- 1R01HL136403-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.